Form 8-K - Current report:
SEC Accession No. 0001641172-25-021911
Filing Date
2025-08-01
Accepted
2025-08-01 16:31:01
Documents
19
Period of Report
2025-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46075
2 EX-1.1 ex1-1.htm EX-1.1 239390
3 EX-5.1 ex5-1.htm EX-5.1 22049
4 EX-99.1 ex99-1.htm EX-99.1 13999
5 EX-99.2 ex99-2.htm EX-99.2 14058
6 GRAPHIC form8-k_001.jpg GRAPHIC 2581
7 GRAPHIC ex5-1_001.jpg GRAPHIC 1942
8 GRAPHIC ex5-1_002.jpg GRAPHIC 3092
  Complete submission text file 0001641172-25-021911.txt   584296

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE dyai-20250730.xsd EX-101.SCH 3008
10 XBRL LABEL FILE dyai-20250730_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE dyai-20250730_pre.xml EX-101.PRE 22354
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3700
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251176635
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)